Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-4-27
pubmed:abstractText
To assess the effect of a combined antithrombin III and C1-esterase inhibitor treatment on intravascular organ fibrin deposition and cardiorespiratory changes following intravenous Escherichia coli endotoxin (lipopolysaccharide [LPS] 80 microg/kg i.v.) exposure.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0090-3493
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
597-604
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10199542-Animals, pubmed-meshheading:10199542-Antithrombin III, pubmed-meshheading:10199542-Antithrombins, pubmed-meshheading:10199542-Complement C1 Inactivator Proteins, pubmed-meshheading:10199542-Disseminated Intravascular Coagulation, pubmed-meshheading:10199542-Dose-Response Relationship, Drug, pubmed-meshheading:10199542-Drug Combinations, pubmed-meshheading:10199542-Endotoxins, pubmed-meshheading:10199542-Escherichia coli Infections, pubmed-meshheading:10199542-Fibrin, pubmed-meshheading:10199542-Hemodynamics, pubmed-meshheading:10199542-Infusions, Intravenous, pubmed-meshheading:10199542-Injections, Intravenous, pubmed-meshheading:10199542-Leukocyte Count, pubmed-meshheading:10199542-Male, pubmed-meshheading:10199542-Rabbits, pubmed-meshheading:10199542-Random Allocation, pubmed-meshheading:10199542-Shock, Septic
pubmed:year
1999
pubmed:articleTitle
Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin.
pubmed:affiliation
Abteilung für Anästhesiologie und Intensivmedizin, Klinikum der Universität-GH Essen, Germany.
pubmed:publicationType
Journal Article